Evaluating the impact of MR-guided radiation therapy on cancer treatment outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The MOMENTUM study is an international registry that collects data on patients undergoing radiation therapy using the MR-Linac technology. This observational cohort study aims to enhance the implementation of MR-guided radiation therapy, which allows for real-time imaging and precision treatment. By gathering technical and clinical data, the study seeks to optimize treatment outcomes, minimize side effects, and improve overall patient survival and quality of life. Participants include cancer patients aged 18 and older who are receiving treatment or imaging on the MR-Linac machine.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
* Patient provides written, informed consent;
* Patient is 18 years old or older.

Exclusion Criteria:

* MRI exclusion criteria, including
* MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.

Where it's running

• Allegheny Health Network
  Pittsburgh, Pennsylvania, United States Recruiting
• Md Anderson Cancer Center
  Houston, Texas, United States Recruiting
• Medical College of Wisconsin
  Milwaukee, Wisconsin, United States Recruiting
• Sunnybrook Health Sciences Centre/Odette Cancer Centre
  Toronto, Ontario, Canada Recruiting
• University Health Network - Princess Margaret Cancer Center
  Toronto, Canada Recruiting
• Odense Universitetshospital
  Odense, Funen, Denmark Recruiting

Study contacts

• Principal investigator: Helena M Verkooijen, Prof, Dr — Universitair Medical Centre Utrecht
• Study coordinator: Tessa Leer
• Email: T.Leer@umcutrecht.nl
• Phone: T +31 (0)88 75 63707

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• Virtual exercise program to preserve function and prevent disability during chemotherapy

  This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

  Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

• Validation of a blood test for early cancer detection and monitoring

  This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.

  Recruiting at 3 sites Adela, Inc · Duarte, California and 16 other locations · NCT05366881

• A resource for collecting cancer data and biospecimens

  This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

  Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

• Collecting blood and leftover tumor tissue to test molecular residual disease (MRD) detection

  This project will test whether blood and leftover tumor tissue from adults with certain solid tumors can be used with Natera's MRD blood tests to find tiny amounts of cancer (ctDNA) after treatment.

  Recruiting Natera, Inc. · Austin, Texas · NCT07318051

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.